Sertraline
1. Pregnancy Evidence & Regulatory Labeling
FDA Pregnancy and Lactation Labeling Rule (PLLR 8.1) & EMA SmPC Section 4.6
Clinical Risk Summary
Sertraline is one of the most widely studied and preferred SSRIs for major depressive disorder and anxiety during pregnancy. Extensive epidemiological data show no significant increase in major structural malformations. Neonates exposed late in the 3rd trimester may experience self-limited Poor Neonatal Adaptation Syndrome (PNAS / neonatal behavioral syndrome) requiring brief observation.
Human Pregnancy Experience & Clinical Studies
Multiple prospective registries and meta-analyses show that sertraline is not associated with cardiovascular or neural tube anomalies.
Animal Reproductive & Developmental Toxicity Data
Studies in rats showed decreased pup survival at doses producing maternal toxicity.
Clinical Considerations for Prescribers
Untreated maternal depression carries significant obstetric and neonatal risks (preterm birth, low birth weight). Maintain stable psychiatric dosing with collaborative obstetric-psychiatric monitoring.
Placental Transfer
Crosses the placenta with lower cord-to-maternal plasma ratio compared to other SSRIs.
2. Lactation & Breastfeeding Safety
NIH / NLM LactMed® Database & FDA Labeling Section 8.2
Summary of Use during Lactation
Sertraline is considered the first-line SSRI of choice during breastfeeding by NIH LactMed, AAP, and ACOG. It exhibits high protein binding (>98%), and breast milk levels and infant serum levels are consistently low or undetectable.
Drug Levels in Breast Milk & Relative Infant Dose
Mean milk-to-plasma ratio is low (~0.89), with peak concentrations occurring 7-8 hours post-dose.
Effects in Breastfed Infants & Monitored Signs
Hundreds of mother-infant pairs studied with zero adverse behavioral or developmental effects reported in breastfed infants.
Effects on Lactation & Milk Production
No adverse impact on lactation.
Alternate Medications with Established Lactation Data
4. Regulatory Source Provenance & Comparison
Direct attribution to official regulatory documents without synthesized consensus
| Regulatory Organization | Jurisdiction | Document / Framework | Effective Date | Official Source Link |
|---|---|---|---|---|
|
National Institutes of Health (NIH) / NLM
LactMed® Database (Drugs and Lactation)
|
United States / Global | evidence_monograph | 2026-08-01 | Official Record |